Capricor Therapeutics launches equity offering following stock surge

Piper Sandler Companies

04/12/2025 21:28

** Capricor Therapeutics' CAPR.O shares up 3.2% at $26.20 i
    n extended trading as it looks to raise equity

    ** San Diego, California-based biotech firm commences stock offering without disclosing deal size

    ** CAPR shares surged 371% to an 8-year high on Weds after co said its experimental cell therapy, deramiocel, slowed the progression of Duchenne muscular dystrophy (DMD) in a late-stage trial

    ** Shares closed down 15.2% at $25.40 on Thurs

      ** With ~45.7 mln shares outstanding, CAPR has ~$1.2 bln market cap

    ** Co intends to use net offering proceeds for continued development and manufacturing of its product candidates, among other purposes

    ** Piper Sandler and Oppenheimer are joint bookrunners

    ** All 10 analysts are bullish on CAPR; median PT of $44 up from $21.50 a month ago, per LSEG

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))